JP2013503173A5 - - Google Patents

Download PDF

Info

Publication number
JP2013503173A5
JP2013503173A5 JP2012526945A JP2012526945A JP2013503173A5 JP 2013503173 A5 JP2013503173 A5 JP 2013503173A5 JP 2012526945 A JP2012526945 A JP 2012526945A JP 2012526945 A JP2012526945 A JP 2012526945A JP 2013503173 A5 JP2013503173 A5 JP 2013503173A5
Authority
JP
Japan
Prior art keywords
theta
degrees
compound
crystalline form
diffraction pattern
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012526945A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013503173A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/046671 external-priority patent/WO2011028580A1/en
Publication of JP2013503173A publication Critical patent/JP2013503173A/ja
Publication of JP2013503173A5 publication Critical patent/JP2013503173A5/ja
Pending legal-status Critical Current

Links

JP2012526945A 2009-08-26 2010-08-25 多環系化合物の新規形態 Pending JP2013503173A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23718009P 2009-08-26 2009-08-26
US61/237,180 2009-08-26
PCT/US2010/046671 WO2011028580A1 (en) 2009-08-26 2010-08-25 Novel forms of a multicyclic compound

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015151114A Division JP2016014029A (ja) 2009-08-26 2015-07-30 多環系化合物の新規形態

Publications (2)

Publication Number Publication Date
JP2013503173A JP2013503173A (ja) 2013-01-31
JP2013503173A5 true JP2013503173A5 (enExample) 2013-10-31

Family

ID=43033463

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2012526945A Pending JP2013503173A (ja) 2009-08-26 2010-08-25 多環系化合物の新規形態
JP2015151114A Ceased JP2016014029A (ja) 2009-08-26 2015-07-30 多環系化合物の新規形態
JP2017169876A Withdrawn JP2018035158A (ja) 2009-08-26 2017-09-04 多環系化合物の新規形態

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015151114A Ceased JP2016014029A (ja) 2009-08-26 2015-07-30 多環系化合物の新規形態
JP2017169876A Withdrawn JP2018035158A (ja) 2009-08-26 2017-09-04 多環系化合物の新規形態

Country Status (19)

Country Link
US (1) US8633314B2 (enExample)
EP (1) EP2470540B1 (enExample)
JP (3) JP2013503173A (enExample)
KR (1) KR20120092100A (enExample)
CN (1) CN102482282A (enExample)
AU (1) AU2010289746B2 (enExample)
BR (1) BR112012004053A2 (enExample)
CA (1) CA2772328C (enExample)
CL (1) CL2012000478A1 (enExample)
DK (1) DK2470540T3 (enExample)
EA (1) EA020756B1 (enExample)
ES (1) ES2572652T3 (enExample)
IL (1) IL218132B (enExample)
MX (1) MX2012002456A (enExample)
MY (1) MY156873A (enExample)
NZ (1) NZ598883A (enExample)
SG (1) SG178852A1 (enExample)
UA (1) UA110604C2 (enExample)
WO (1) WO2011028580A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA020756B1 (ru) * 2009-08-26 2015-01-30 Сефалон, Инк. Новые формы полициклического соединения
AU2015353549A1 (en) * 2014-11-26 2017-06-01 Cephalon, Inc. Crystalline forms of PARP inhibitors
EP3478286B1 (en) 2016-06-29 2024-01-03 Tesaro, Inc. Methods of treating ovarian cancer
MX2019011496A (es) 2017-03-27 2020-01-23 Tesaro Inc Composiciones de niraparib.
BR112020006039A2 (pt) 2017-09-26 2020-10-06 Tesaro, Inc. formulações de niraparibe
CN109632555B (zh) * 2018-12-28 2021-07-27 上海新黄河制药有限公司 一种富马酸福莫特罗无定型含量的动态蒸汽吸附分析方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7122679B2 (en) * 2000-05-09 2006-10-17 Cephalon, Inc. Multicyclic compounds and the use thereof
US20060276497A1 (en) 2000-05-09 2006-12-07 Cephalon, Inc. Novel multicyclic compounds and the use thereof
CA2620052A1 (en) * 2005-08-24 2007-03-01 Inotek Pharmaceuticals Corporation Indenoisoquinolinone analogs and methods of use thereof
CN101784268B (zh) * 2006-11-20 2013-06-19 赛福伦公司 使用辐射敏化剂使肿瘤对辐射敏化的方法
EA020756B1 (ru) * 2009-08-26 2015-01-30 Сефалон, Инк. Новые формы полициклического соединения

Similar Documents

Publication Publication Date Title
JP2013503173A5 (enExample)
US20170267645A1 (en) Enzalutamide polymorphic forms and its preparation
JP5535082B2 (ja) ボセンタン、その多形形態及びその塩の合成方法
JP2018528199A5 (enExample)
JP2014524920A5 (enExample)
JP2020033359A5 (enExample)
CN107635969B (zh) 恩杂鲁胺结晶形式的制造方法
JP5390617B2 (ja) アデホビルジピボキシルの精製方法
TW201609787A (zh) 達格列淨新穎特別晶型及其製備方法
JP2011500780A5 (enExample)
JP7539222B2 (ja) Dota合成
CN102643275A (zh) 一种达莎替尼n-6晶型新的制备方法
WO2017092702A1 (zh) 奥贝胆酸晶型ⅱ及其制备方法和用途
CN102924474A (zh) 一种氯吡格雷硫酸氢盐晶型ⅰ的制备方法
CN107188799A (zh) 芬布芬共晶及其制备方法与应用
CN104185621B (zh) 用于制备3-甲磺酰基丙腈的方法
CN103880829B (zh) 一种阿齐沙坦晶体及其制备方法和用途
WO2017131218A1 (ja) アジルサルタン及びその製造方法
JP2010132561A (ja) コハク酸シベンゾリンの新規a型結晶及びその製造方法
JP2016504364A (ja) コビシスタット塩
CN104703967B (zh) 氟伏沙明游离碱的精制方法及利用其的高纯度马来酸氟伏沙明的制备方法
WO2012168948A2 (en) Process for febuxostat
CN103664753B (zh) 制备阿扎那韦硫酸氢盐a型结晶的方法
WO2014195977A2 (en) Novel polymorphs of vismodegib
JP7177796B2 (ja) アジルサルタンa型結晶の製造方法